 |
0 Diseases |  |
137 Trials |
|
137 Trials |  |
5343 News |  |
| «12...79808182838485868788899091» |
- | Noxafil (posaconazole) / Merck (MSD)
New trial: Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=1000, Recruiting, Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
- | Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
New trial: TEDIZOAM: Tedizolid Prolonged Treatment for Prosthetic Joint Infections (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=35, Not yet recruiting, Sponsor: Tourcoing Hospital
- | Dexilant (dexlansoprazole) / Takeda
Trial primary completion date: Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori (clinicaltrials.gov) - Nov 27, 2017
P4, N=180, Recruiting, Sponsor: Ramathibodi Hospital
Trial primary completion date: Jul 2017 --> Dec 2017
- ||||||| Taigexyn (nemonoxacin) / TaiGen
Trial completion, Trial primary completion date: A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP (clinicaltrials.gov) - Oct 16, 2017
P3, N=603, Completed, Sponsor: TaiGen Biotechnology Co., Ltd.
Trial primary completion date: Jul 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017
- ||||||| levofloxacin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Surgery: Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery (clinicaltrials.gov) - Oct 12, 2017
P3, N=576, Completed, Sponsor: Santen Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed | N=430 --> 576 | Trial primary completion date: Sep 2016 --> Mar 2017
- | Trial primary completion date: Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - Oct 7, 2017
P4, N=1786, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed | N=430 --> 576 | Trial primary completion date: Sep 2016 --> Mar 2017 Trial primary completion date: Jun 2019 --> Mar 2018
- | Trial primary completion date: Personalized Treatment for Refractory H Pylori Infection (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=150, Recruiting, Sponsor: Kaohsiung Veterans General Hospital.
Trial primary completion date: Jun 2019 --> Mar 2018 Trial primary completion date: Dec 2016 --> Dec 2018
- ||||| Xerava (eravacycline) / SOM Biotech, Ewha Womans University, PAION, Innoviva
Enrollment closed: IGNITE3: Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections (clinicaltrials.gov) - Sep 25, 2017
P3, N=1200, Active, not recruiting, Sponsor: Tetraphase Pharmaceuticals, Inc.
Trial primary completion date: Dec 2016 --> Dec 2018 Recruiting --> Active, not recruiting
- | Enrollment change, Trial withdrawal: DAZZLE: Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin (clinicaltrials.gov) - Sep 11, 2017
P3, N=0, Withdrawn, Sponsor: Boston University
Recruiting --> Active, not recruiting N=300 --> 0 | Not yet recruiting --> Withdrawn
- | levofloxacin / Generic mfg.
Trial primary completion date: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Sep 7, 2017
P3, N=740, Active, not recruiting, Sponsor: Children's Oncology Group
N=300 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Dec 2017 --> Jun 2017
- | levofloxacin / Generic mfg., clarithromycin / Generic mfg.
Enrollment open: Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori (clinicaltrials.gov) - Sep 6, 2017
P4, N=100, Recruiting, Sponsor: Damascus Hospital
Trial primary completion date: Dec 2017 --> Jun 2017 Not yet recruiting --> Recruiting
- | New trial: MAPPAC: Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=200, Enrolling by invitation, Sponsor: Turku University Hospital
- | Enrollment open: APPACIII: Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis (clinicaltrials.gov) - Aug 11, 2017
P=N/A, N=147, Enrolling by invitation, Sponsor: Turku University Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Enrolling by invitation
- | New trial: APPACII: Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis (clinicaltrials.gov) - Aug 1, 2017
P=N/A, N=552, Recruiting, Sponsor: Turku University Hospital
- | New P4 trial: InDEX: The Individualized M(X) Drug-resistant TB Treatment Strategy Study (clinicaltrials.gov) - Aug 1, 2017
P4, N=300, Recruiting, Sponsor: Centre for the AIDS Programme of Research in South Africa
- | New trial: APPACIII: Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis (clinicaltrials.gov) - Jul 30, 2017
P=N/A, N=147, Not yet recruiting, Sponsor: Turku University Hospital
- | levofloxacin / Generic mfg.
Trial completion, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Jul 28, 2017
P2, N=111, Completed, Sponsor: Boston University
Not yet recruiting --> Enrolling by invitation Active, not recruiting --> Completed
- | vancomycin / Generic mfg., levofloxacin / Generic mfg.
New trial: ANTHEM: Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria (clinicaltrials.gov) - Jul 21, 2017
P=N/A, N=150, Recruiting, Sponsor: Menzies School of Health Research
- | levofloxacin / Generic mfg.
New P4 trial, Nontuberculous mycobacteria: Linezolid for Treatment of Nontuberculous Mycobacterial Diseases (clinicaltrials.gov) - Jul 18, 2017
P4, N=50, Not yet recruiting, Sponsor: Mahidol University
- | levofloxacin / Generic mfg.
Trial primary completion date: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Jul 12, 2017
P3, N=740, Active, not recruiting, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Dec 2017
- ||||| levofloxacin / Generic mfg., prulifloxacin / Generic mfg.
New P2 trial: Prulifloxacin in Chronic Bacterial Prostatitis (CBP) (clinicaltrials.gov) - Jun 27, 2017
P2, N=148, Recruiting, Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A
- | clarithromycin / Generic mfg.
Enrollment open: Hepys (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=2500, Recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: Jun 2017 --> Dec 2017 Not yet recruiting --> Recruiting
- | levofloxacin / Generic mfg., fluconazole oral / Generic mfg., acyclovir / Generic mfg.
Enrollment change, IO biomarker: ZENITH: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies (clinicaltrials.gov) - Jun 17, 2017
P2, N=50, Recruiting, Sponsor: Azienda Ospedaliero, Universitaria Pisana
Not yet recruiting --> Recruiting N=20 --> 50
- | levofloxacin / Generic mfg., fluconazole oral / Generic mfg., acyclovir / Generic mfg.
New P2 trial, IO biomarker: ZENITH: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies (clinicaltrials.gov) - Jun 12, 2017
P2, N=50, Recruiting, Sponsor: Azienda Ospedaliero, Universitaria Pisana
- | levofloxacin / Generic mfg.
New trial: Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy (clinicaltrials.gov) - Jun 5, 2017
P=N/A, N=300, Not yet recruiting, Sponsor: Mansoura University
- | Trial primary completion date: Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis (clinicaltrials.gov) - Jun 5, 2017
P2, N=128, Recruiting, Sponsor: Vanderbilt University
N=20 --> 50 Trial primary completion date: Mar 2017 --> Mar 2019
- | levofloxacin / Generic mfg.
Trial primary completion date: RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis (clinicaltrials.gov) - May 24, 2017
P=N/A, N=82, Recruiting, Sponsor: Fu Xing Hospital, Capital Medical University
Trial primary completion date: Mar 2017 --> Mar 2019 Trial primary completion date: Dec 2016 --> Dec 2017
- | Xefo (lornoxicam) - Old API Wind / down, Takeda, Vesicare (solifenacin) / Astellas
Enrollment closed, Adverse events: Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? (clinicaltrials.gov) - May 23, 2017
P4, N=150, Active, not recruiting, Sponsor: Mansoura University
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Active, not recruiting
- | levofloxacin / Generic mfg., fluconazole oral / Generic mfg., acyclovir / Generic mfg.
New P2 trial, IO biomarker: ZENITH: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies (clinicaltrials.gov) - May 18, 2017
P2, N=20, Recruiting, Sponsor: Azienda Ospedaliero, Universitaria Pisana
- | levofloxacin / Generic mfg., itraconazole / Generic mfg., voriconazole / Generic mfg.
New trial: UVX as an Adjuvant in the Treatment of Fungal Keratitis (clinicaltrials.gov) - May 3, 2017
P=N/A, N=20, Active, not recruiting, Sponsor: Farabi Eye Hospital
- | New P4 trial: Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment (clinicaltrials.gov) - May 3, 2017
P4, N=120, Not yet recruiting, Sponsor: Yanqing Li
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Enrollment closed: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Apr 29, 2017
P=N/A, N=20, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | nitazoxanide / Generic mfg.
Trial primary completion date: Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori (clinicaltrials.gov) - Apr 25, 2017
P3, N=120, Recruiting, Sponsor: Sherief Abd-Elsalam
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Dec 2018
- | Trial initiation date: Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment (clinicaltrials.gov) - Apr 25, 2017
P4, N=480, Recruiting, Sponsor: Shandong University
Trial primary completion date: Dec 2016 --> Dec 2018 Initiation date: Apr 2016 --> Apr 2017
- | ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
Enrollment open: Antibiotics to Decrease Post ERCP Cholangitis (clinicaltrials.gov) - Apr 20, 2017
P4, N=200, Recruiting, Sponsor: University of Southern California
Initiation date: Apr 2016 --> Apr 2017 Not yet recruiting --> Recruiting
- | levofloxacin / Generic mfg., clarithromycin / Generic mfg.
Enrollment change, Trial initiation date: Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori (clinicaltrials.gov) - Apr 11, 2017
P4, N=100, Not yet recruiting, Sponsor: Damascus Hospital
Not yet recruiting --> Recruiting N=400 --> 100 | Initiation date: Feb 2017 --> Jun 2017
- | levofloxacin / Generic mfg.
New trial: Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=217, Completed, Sponsor: Federal University of S
- | Trial primary completion date: Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - Apr 7, 2017
P4, N=1786, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=400 --> 100 | Initiation date: Feb 2017 --> Jun 2017 Trial primary completion date: Jun 2018 --> Jun 2019
- | AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
New trial: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=20, Recruiting, Sponsor: Washington University School of Medicine
- | Trial completion: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection (clinicaltrials.gov) - Mar 28, 2017
P4, N=212, Completed, Sponsor: Zahra Vahdat Shariatpanahi
Trial primary completion date: Jun 2018 --> Jun 2019 Recruiting --> Completed
- | linezolid oral / Generic mfg.
Enrollment open: PRESTO:Osteo: Patients Response to Early Switch To Oral:Osteomyelitis Study (clinicaltrials.gov) - Mar 24, 2017
P, N=456, Recruiting, Sponsor: Julio Ramirez
Recruiting --> Completed Not yet recruiting --> Recruiting
- | Dexilant (dexlansoprazole) / Takeda
New P4 trial: Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori (clinicaltrials.gov) - Mar 22, 2017
P4, N=180, Recruiting, Sponsor: Ramathibodi Hospital
- | ceftriaxone / Generic mfg., levofloxacin / Generic mfg.
New P4 trial: Antibiotics to Decrease Post ERCP Cholangitis (clinicaltrials.gov) - Mar 22, 2017
P4, N=200, Not yet recruiting, Sponsor: University of Southern California
- | levofloxacin / Generic mfg.
Trial primary completion date, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Mar 1, 2017
P2, N=111, Active, not recruiting, Sponsor: Boston University
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2017 --> Jul 2017
- | levofloxacin / Generic mfg., rifampicin / Generic mfg.
Enrollment open: TBM-KIDS: Optimizing Treatment to Improve TBM Outcomes in Children (clinicaltrials.gov) - Feb 27, 2017
P1/2, N=120, Recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Mar 2017 --> Jul 2017 Not yet recruiting --> Recruiting
- | Enrollment open, Trial initiation date, Trial primary completion date: Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment (clinicaltrials.gov) - Feb 27, 2017
P4, N=480, Recruiting, Sponsor: Shandong University
Not yet recruiting --> Recruiting Initiation date: Dec 2016 --> Feb 2016 | Trial primary completion date: Mar 2017 --> Jul 2017 | Not yet recruiting --> Recruiting
- | levofloxacin / Generic mfg., fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Clinical: Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=1000, Recruiting, Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Initiation date: Dec 2016 --> Feb 2016 | Trial primary completion date: Mar 2017 --> Jul 2017 | Not yet recruiting --> Recruiting Trial primary completion date: Nov 2016 --> Nov 2017
- | Enrollment open: Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment (clinicaltrials.gov) - Feb 17, 2017
P4, N=500, Recruiting, Sponsor: Shanghai Jiao Tong University School of Medicine
Trial primary completion date: Nov 2016 --> Nov 2017 Not yet recruiting --> Recruiting
- ||||| levofloxacin / Generic mfg.
Enrollment closed: Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (clinicaltrials.gov) - Feb 15, 2017
P3, N=740, Active, not recruiting, Sponsor: Children's Oncology Group
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- levofloxacin / Generic mfg.
Enrollment closed, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Feb 15, 2017
P2, N=111, Active, not recruiting, Sponsor: Boston University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting